The role of Eph receptors and Ephrins in the skin

International Journal of Dermatology

Volumn 55, Issue 1, 2016, Pages 3-10

  Wijeratne, Dulharie T ^a   Rodger, Jennifer ^a   Wood, Fiona M ^a,b   Fear, Mark W ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Fiona Wood Foundation   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN; EPHRIN A2; EPHRIN A3; EPHRIN A4; EPHRIN A5; EPHRIN B2; EPHRIN B4; EPHRIN RECEPTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

BINDING AFFINITY; EMBRYO DEVELOPMENT; EPIDERMIS; HAIR FOLLICLE; HISTOGENESIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; POSTNATAL DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASE; SKIN FIBROBLAST; SKIN NERVE; TISSUE REPAIR; CELL DIFFERENTIATION; ENZYMOLOGY; FEMALE; FIBROBLAST; MALE; METABOLISM; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SKIN TUMOR;

BIOMARKERS; CELL DIFFERENTIATION; EPHRINS; EPIDERMIS; FEMALE; FIBROBLASTS; HUMANS; MALE; RECEPTORS, EPH FAMILY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SKIN DISEASES; SKIN NEOPLASMS;

EID: 84953839795     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12968     Document Type: Review

References (62)

1. Eph Nomenclature Committee. Unified nomenclature for Eph family receptors and their ligands, the Ephrins. Cell 1997; 90: 403-404.
2. Flanagan JG, Vanderhaeghen P. The Ephrins and Eph receptors in neural development. Annu Rev Neurosci 1998; 21: 309-345.
3. Menzel P, Valencia F, Godement P, et al. Ephrin-A6, a new ligand for EphA receptors in the developing visual system. Dev Biol 2001; 230: 74-88.
4. Murai KK, Pasquale EB. 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci 2003; 116: 2823-2832.
5. O'Leary DDM, Wilkinson DG. Eph receptors and Ephrins in neural development. Curr Opin Neurobiol 1999; 9: 65-73.
6. Himanen JP, Chumley MJ, Lackmann M, et al. Repelling class discrimination: Ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 2004; 7: 501-509.
7. Hafner C, Becker B, Landthaler M, et al. Expression profile of Eph receptors and Ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 2006; 19: 1369-1377.
8. Genander M, Holmberg J, Frisén J. Ephrins negatively regulate cell proliferation in the epidermis and hair follicle. Stem Cells 2010; 28: 1196-1205.
9. Udayakumar D, Zhang G, Ji Z, et al. EphA2 is a critical oncogene in melanoma. Oncogene 2011; 30: 4921-4929.
10. Eskandarpour M, Huang F, Reeves KA, et al. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro. Int J Cancer 2009; 124: 16-26.
11. Hess AR, Seftor EA, Gruman LM, et al. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 2006; 5: 228-233.
12. Chen LX, He YJ, Zhao SZ, et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer Biol Ther 2011; 11: 229-235.
13. Robbins CR. Skin. In: Encyclopedia of Human Biology, 2nd edn. San Diego, CA: Academic Press, 1997: 39-47.
14. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
15. Miao H, Wang B. Eph/Ephrin signaling in epithelial development and homeostasis. Int J Biochem Cell Biol 2009; 41: 762-770.
16. Tanaka M, Kamata R, Sakai R. Phosphorylation of Ephrin-B1 via the interaction with claudin following cell-cell contact formation. EMBO J 2005; 24: 3700-3711.
17. Tanaka M, Kamata R, Sakai R. EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability. J Biol Chem 2005; 280: 42375-42382.
18. Orsulic S, Kemler R. Expression of Eph receptors and Ephrins is differentially regulated by E-cadherin. J Cell Sci 2000; 113: 1793-1802.
19. Zantek ND, Azimi M, Fedor-Chaiken M, et al. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 1999; 10: 629-638.
20. Walsh R, Blumenberg M. Specific and shared targets of Ephrin A signaling in epidermal keratinocytes. J Biol Chem 2011; 286: 9419-9428.
21. Avouac J, Clemessy M, Distler JH, et al. Enhanced expression of Ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis. Rheumatology 2011; 50: 1494-1504.
22. Hendrix S, Picker B, Liezmann C, et al. Skin and hair follicle innervation in experimental models: a guide for the exact and reproducible evaluation of neuronal plasticity. Exp Dermatol 2008; 17: 214-227.
23. Paus R, Peters EMJ, Eichmuller S, et al. Neural mechanisms of hair growth control. J Invest Derm Symp Proc 1997; 2: 61-68.
24. Altun V, Hakvoort TE, van Zuijlen PPM, et al. Nerve outgrowth and neuropeptide expression during the remodeling of human burn wound scars: a 7-month follow-up study of 22 patients. Burns 2001; 27: 717-722.
25. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24: 739-768.
26. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 1979; 310: 175-183.
27. Schäffer M, Beiter T, Becker HD, et al. Neuropeptides: mediators of inflammation and tissue repair? Arch Surg 1998; 133: 1107-1116.
28. Tanaka T, Danno K, Ikai K, et al. Effects of substance P and substance K on the growth of cultured keratinocytes. J Investig Dermatol 1988; 90: 399-401.
29. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993; 363: 159-163.
30. Albers KM, Wright DE, Davis BM. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci 1994; 14: 1422-1432.
31. LeMaster AM, Krimm RF, Davis BM, et al. Overexpression of brain-derived neurotrophic factor enhances sensory innervation and selectively increases neuron number. J Neurosci 1999; 19: 5919-5931.
32. Bennett DL, Averill S, Clary DO, et al. Postnatal changes in the expression of the trkA high-affinity NGF receptor in primary sensory neurons. Eur J Neurosci 1996; 8: 2204-2208.
33. Rice FL, Albers KM, Davis BM, et al. Differential dependency of unmyelinated and A[delta] epidermal and upper dermal innervation on neurotrophins, Trk receptors, and p75LNGFR. Dev Biol 1998; 198: 57-81.
34. Moss A, Alvares D, Meredith-Middleton J, et al. Ephrin-A4 inhibits sensory neurite outgrowth and is regulated by neonatal skin wounding. Eur J Neurosci 2005; 22: 2413-2421.
35. Eberhart J, Swartz M, Koblar SA, et al. Expression of EphA4, Ephrin-A2 and Ephrin-A5 during axon outgrowth to the hindlimb indicates potential roles in pathfinding. Dev Neurosci 2000; 22: 237-250.
36. Eberhart J, Swartz ME, Koblar SA, et al. EphA4 constitutes a population-specific guidance cue for motor neurons. Dev Biol 2002; 247: 89-101.
37. Eberhart J, Barr J, O'Connell S, et al. Ephrin-A5 Exerts positive or inhibitory effects on distinct subsets of EphA4-positive motor neurons. J Neurosci 2004; 24: 1070-1078.
38. Muñoz LM, Zayachkivsky A, Kunz RB, et al. Ephrin-A5 inhibits growth of embryonic sensory neurons. Dev Biol 2005; 283: 397-408.
39. Wang L, Klein R, Zheng B, et al. Anatomical coupling of sensory and motor nerve trajectory via axon tracking. Neuron 2011; 71: 263-277.
40. Wijeratne DT, Rodger J, Wallace HJ, et al. Ephrin-A2 and Ephrin-A5 are important for the functional development of cutaneous innervation in a mouse model. J Invest Dermatol 2015; 135: 632-635.
41. Reynolds ML, Fitzgerald M. Long-term sensory hyperinnervation following neonatal skin wounds. J Comp Neurol 1995; 358: 487-498.
42. Zhang LQ, Laato M. Innervation of normal and hypertrophic human scars and experimental wounds in the rat. Ann Chir Gynaecol 2001; 90(Suppl. 215): 29-32.
43. Aldskogius H, Hermanson A, Jonsson CE. Reinnervation of experimental superficial wounds in rats. Plast Reconstr Surg 1987; 4: 595-599.
44. Scott JR, Muangman P, Gibran NS. Making sense of hypertrophic scar: a role for nerves. Wound Repair Regen 2007; 15: S27-S31.
45. Hamed K, Giles N, Anderson J, et al. Changes in cutaneous innervation in patients with chronic pain after burns. Burns 2011; 37: 631-637.
46. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev 2001; 81: 449-494.
47. Egawa G, Osawa M, Uemura A, et al. Transient expression of Ephrin B2 in perinatal skin is required for maintenance of keratinocyte homeostasis. J Invest Dermatol 2009; 129: 2386-2395.
48. Genander M, Frisén J. Ephrins and Eph receptors in stem cells and cancer. Curr Opin Cell Biol 2010; 22: 611-616.
49. Tumbar T, Guasch G, Greco V, et al. Defining the epithelial stem cell niche in skin. Science 2004; 303: 359-363.
50. Yamada Y, Midorikawa T, Oura H, et al. Ephrin-A3 not only increases the density of hair follicles but also accelerates anagen development in neonatal mice. J Dermatol Sci 2008; 52: 178-185.
51. Kulski JK, Kenworthy W, Bellgard M, et al. Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. J Mol Med (Berl) 2005; 83: 964-975.
52. Piruzian E, Bruskin S, Ishkin A, et al. Integrated network analysis of transcriptomic and proteomic data in psoriasis. BMC Syst Biol 2010; 4: 41.
53. Gordon K, Kochkodan JJ, Blatt H, et al. Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis. J Invest Dermatol 2013; 133: 712-722.
54. Anderson JR, Zorbas JS, Phillips JK, et al. Systemic decreases in cutaneous innervation after burn injury. J Invest Dermatol 2010; 130: 1948-1951.
55. Ward RS, Saffle JR, Schnebly WA, et al. Sensory loss over grafted areas in patients with burns. J Burn Care Rehabil 1989; 10: 536-538.
56. Samaka RM, Gaber MA. Ephrin A4 Immunohistochemical expression in cutaneous melanoma. J Egypt Women Dermatol Soc 2010; 7: 97-104.
57. Guo H, Miao H, Gerber L, et al. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res 2006; 66: 7050-7058.
58. Wang Z, Cohen K, Shao Y, et al. Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels. Blood 2004; 103: 100-109.
59. Makinen T, Adams RH, Bailey J, et al. PDZ interaction site in Ephrinb2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005; 19: 397-410.
60. Larsen AB, Pedersen MW, Stockhausen MT, et al. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Mol Cancer Res 2007; 5: 283-293.
61. Miao H, Wei BR, Peehl DM, et al. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 2001; 3: 527-530.
62. Parri M, Buricchi F, Taddei ML, et al. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J Biol Chem 2005; 280: 34008-34018.